European family-office capital is not one uniform funding market. A Swiss mental-health venture arm, an Austrian B2B investor and a UK family office funding scientific startups can all be relevant, but they answer different company decisions. Compare the actual investing strategy, not the family's wealth or office address. This guide covers 20 direct-company routes and clearly labels broader family-backed platforms.
Build a European family-capital mandate map
- Start with the company: record incorporation, operations, founders and customer markets separately.
- Choose the capital route: direct startup equity, a family-backed venture team, a later company strategy or a fund allocation.
- Check entry evidence: prototype, first revenue, repeat sales or scientific development are different filters.
- Name the country question: a Europe label does not settle the precise investing entity, process or market restrictions.
Compare 20 family-capital startup investor routes
Sources reviewed November 13, 2026. This is a selected research directory, not a ranking. Company entry stages, fund allocation and later-stage strategies are kept separate. On mobile, scroll the comparison sideways.
| Investor | Product focus | Stage or route | Geographic filter |
|---|---|---|---|
| Reimann Investors | B2B software, AI and fintech | Seed and Series A; validated customer value | Germany, Austria and Switzerland |
| Mutschler Ventures | Fintech, digital health, software, cleantech and mobility | Seed follow-on; initial revenue and validation | DACH-focused with broader portfolio experience |
| Wille Finance | ICT and life sciences | Venture: Series A and B; buyout is separate | European venture strategy; DACH buyout scope is distinct |
| Winterberg Group | Industrial technology and emerging-middle-class themes | Seed and Round A; mature buyouts are separate | Europe, US and South Africa under early-growth criteria |
| Armada Investment | Technology and scientific company building | All venture stages; company-specific | Europe and the United States |
| Halfmeyer Ventures | Software-led health tech, AI, commerce and automation | Pre-seed and seed; product, prototype or validated problem | Europe and beyond; no Berlin-residence requirement |
| Kodori | Kodori Ventures focuses on mental health | Early-stage venture arm; precise entry policy to confirm | Zug-based; confirm company-market scope |
| RM Beteiligungsverwaltung | Early-stage company investment; sector policy to confirm | Early-stage companies; detailed criteria not published | German-based; confirm the company's geographic fit |
| BLN Capital | Technology and gaming | Pre-seed and seed for direct venture strategy | Europe and the United States |
| Stinson | Sustainable company development across industries | Startups and established companies; entry stage not specified | Germany-based with an international network |
| ROI Ventures | Technology-driven B2B startups and consumer brands | Early-stage B2B; consumer angel and pre-seed; separate growth route | Europe; Austrian base |
| SABER | Multi-sector direct startup investment | Private growth companies; precise initial round to confirm | Europe, the US and Israel; Vienna-based |
| Apeiron Investment Group | Transformative technology and human health | Incubation to growth and public holdings; strategy-specific | Global; primary US focus; European teams |
| Adeline Arts & Science | Frontier technology, AI, science, climate and health | Pre-seed through Series A | UK and European sourcing, including DACH; global outlook |
| CPT Capital | Alternative protein, food technology and enabling infrastructure | Pre-seed and seed, with follow-on investing | Global, including Europe and Israel |
| AFP Capital | Innovative technology; ESG considerations | Pre-seed and seed; can lead or co-invest | Italy-centered startup ecosystem |
| Korys | Energy transition, healthy living and conscious consumption | Fast-growing companies; precise entry round to confirm | European family-capital platform; verify the specific market |
| Smedvig Ventures | B2B technology | B2B technology with early commercial traction | UK, Nordics and Benelux are specifically named |
| Motier Ventures | Technology, including a documented AI portfolio | Early company angel investment and follow-on | Paris-based; confirm geography for the company |
| B-FLEXION | Life sciences and transformative operating businesses | Strategy-specific company investment | Europe and US offices; investing entity matters |
Read provider criteria and approach routes
1. Reimann Investors
Family-office-backed venture platform. The published DACH mandate is specific enough to screen a company before outreach. Show validated customer value and the route to a larger market. Do not transfer an affiliated asset-management offering or a historical fund's stage range into the startup pitch.
Founder route: Pitch to us route. Official criteria.
2. Mutschler Ventures
Single-family-office venture arm. Mutschler asks for initial revenue and validation and positions itself as a seed follow-on investor. A pre-revenue idea-only pitch is therefore a different case. Its current exclusions include biotech and medtech, which must not be relabeled as digital-health eligibility.
Founder route: Published direct inbox; warm introductions welcomed. Official criteria.
3. Wille Finance
Single-family office. Wille places venture and buyout criteria alongside one another. Use the European Series A-and-B company strategy when evaluating a startup, not the buyout column. The team invites cases that fit its profile, making the actual technology and development milestone central to the approach.
Founder route: Private equity team contact on the official page. Official criteria.
4. Winterberg Group
Multi-family investment office. Its early-growth strategy and mature industrial buyout strategy answer different funding jobs. Select the seed or Round A route and explain the growth evidence, team and market. A European office alone does not mean a company qualifies for both strategies.
Founder route: Official Contact Form. Official criteria.
5. Armada Investment
Founder-family proprietary investment office. Armada states that it invests its own capital and backs venture founders in Europe and the US across stages. The founder-capital structure can be relevant to an unusual development path, but the company still needs a specific technological and commercial case.
Founder route: Published corporate contact information. Official criteria.
6. Halfmeyer Ventures
Family office and venture studio. A software-led company can qualify before revenue when it has relevant proof. A hardware-only or idea-only proposition is not equivalent. Explain whether operator involvement would help, and distinguish a direct investment request from incubation or paid advisory work.
Founder route: Public cold-pitch form. Official criteria · Supporting official evidence.
7. Kodori
Swiss-family-office-backed private investment company. Kodori describes a specific mental-health venture focus within a broader family-backed investment company. Identify that strategy first. An old investment elsewhere in the parent portfolio is not proof that every cybersecurity, consumer or medical startup is currently in scope.
Founder route: Official contact information. Official criteria.
8. RM Beteiligungsverwaltung
Entrepreneur's private investment company. Roland Metzger's private investment company identifies early-stage companies as its present emphasis. That is useful as an initial stage screen, but not a published ticket or sector commitment. Approach with the company's concrete proof and one question about current fit.
Founder route: Official Contact page. Official criteria.
9. BLN Capital
Founder-owned private investment office. BLN separates direct early-stage investments from fund commitments. For a company raise, use the venture strategy rather than an LP-facing relationship. Its operator background is relevant to product and growth discussions, but it does not remove the need for an actual market and stage match.
Founder route: Official Contact us route. Official criteria.
10. Stinson
Single-family office. Stinson's current strategy expressly includes startups and established companies. Treat that as a reason to research the team, not an automatic pre-seed qualification. Explain the business model, development potential and operating work where a hands-on family partner could contribute.
Founder route: Official contact email and Contact section. Official criteria.
11. ROI Ventures
Family office. ROI publishes different propositions for early technology companies, retail consumer brands and later growth or secondaries. A B2B founder should not reuse a consumer-brand ticket as a blanket term. Make the product, buyer and relevant investment route explicit.
Founder route: Get In Touch page. Official criteria.
12. SABER
Single-family office. SABER's official company profile distinguishes direct startups from fund allocation and names a growth-company preference. That is not evidence of idea-stage eligibility. No working public deck form was verified, so treat the company profile as a research route, not an open funding application.
Founder route: Official company profile; no public deck form verified. Official company profile.
13. Apeiron Investment Group
Founder-owned proprietary investment platform. Apeiron separates proprietary company investing from anchor LP positions and GP stakes. A startup should identify the direct-company thesis and actual investing entity. Its global scope does not mean every European company or sector fits the present priorities.
Founder route: Official contact form. Official criteria.
14. Adeline Arts & Science
Family office. Adeline's early-stage strategy combines science and technology with a long-term view. Its team describes UK and DACH experience. Explain the technical leverage and next proof point, and use the startup pitch route rather than a scientific-research or arts request.
Founder route: Pitch us form on the official site. Official criteria.
15. CPT Capital
Private-family-office venture arm. CPT's worldwide mandate and early entry stage make it a specific route for alternative-protein companies, including European teams. It is not a general climate or consumer-food investor. Match the technological mechanism and show why it fits the future-protein strategy.
Founder route: Published investment-opportunity email. Official criteria.
16. AFP Capital
Privately owned family office. AFP expressly describes family-office capital for pre-seed and seed startups. Its Italian ecosystem and industrial and ICT networks make it different from a pan-European generalist. Separate direct company investment from the investment vehicles displayed in its portfolio.
Founder route: Submit your startup route. Official criteria.
17. Korys
Colruyt-family investment company. Korys combines company participations, funds and other assets around defined investment themes. A startup should identify the direct-company team and explain the relevant operating problem. A renewable-energy asset and a technology company are not the same financing proposition.
Founder route: Official corporate contact route. Official criteria.
18. Smedvig Ventures
Dedicated family-office venture strategy. The parent family office publishes a more specific geography than a loose Europe label: UK, Nordics and Benelux. Its commercial-traction focus also differs from an idea-stage angel. Verify the current venture team and round fit rather than use unrelated Smedvig operating investments as venture criteria.
Founder route: Official Smedvig contact route. Official criteria.
19. Motier Ventures
Venture family office. Motier describes itself as a venture family office and publishes an early-company investment proposition. Its operating ecosystem is distinct from a conventional institution-only fund. Match the actual product and market to the current team, rather than assume all companies can use the same corporate network.
Founder route: Official contact route on the site. Official criteria.
20. B-FLEXION
Family-rooted private entrepreneurial investment platform. B-FLEXION's principal company investing is separate from its affiliated investment-management partnerships. For a European healthcare company, identify the relevant life-sciences platform and development stage. Do not count every affiliate as a second family office with identical eligibility.
Founder route: Official Contact page. Official criteria.
A European address is not a continental mandate
Reimann names Germany, Austria and Switzerland. AFP is closely connected to Italy. Smedvig names the UK, Nordics and Benelux. CPT states a worldwide alternative-protein strategy. These are useful differences, not administrative fine print: they determine where a founder should spend the next hour of research.
Which European country is best for startups?
For this investor decision, there is no universal best country. Begin with the location of the team, customers, research and operations, then look for capital whose published mandate fits that reality. Do not move or restructure a company merely to match a directory entry. Formation, tax and regulatory questions need qualified advice.
Worked example: a European industrial-software company
Fictional example: a company building industrial workflow software has paying customers in Austria and plans to sell across Europe. It researches Reimann because DACH and B2B software are explicit, Mutschler because it has initial revenue and a software product, and Wille only if the current Series A or B proposition matches the round. A seed-stage company does not become Series A-ready because a larger investor looks attractive.
The founders retain CPT only if the product genuinely enables alternative proteins; an industrial label alone is insufficient. They use one evidence note per route and remove providers whose geographic or stage requirements do not fit.
Copy the European mandate-map worksheet
Use one line per actual investing platform, not one per office. Keep the latest source and the open eligibility question alongside the contact in Finta.
EUROPEAN FAMILY-CAPITAL MANDATE MAP
Company: product / buyer / next milestone
Incorporation / operations / customers:
Country or region being researched:
Investor / parent / actual investing team:
Provider structure and direct-company evidence:
Published stage and current company evidence:
Geographic mandate versus office location:
Sector match and exclusion:
Source URL and date:
Public approach route or route not verified:
Question to resolve before sharing a deck:
Relationship owner / next action / review date:Ask Aurora, Claude or Codex to review your shortlist
Supply your facts and the official sources. Review the result before acting; this is a research aid, not automatic outreach.
Compare these European family-capital routes for the company facts and official sources supplied. Keep incorporation, operating markets and investor offices separate. Identify direct-company investing versus fund allocation, the actual venture team, documented entry evidence, sector fit and geographic restrictions. Do not assume that a European office creates a Europe-wide mandate. Deduplicate parents and venture arms, mark unsupported fields unknown, and return a short research queue with disqualifiers, one eligibility question and a next action for each retained match. Do not give formation, legal or tax advice and do not send outreach.Methodology and related guides
The Finta Editorial Team reviewed investor-controlled strategy, criteria, team and contact information. We count each platform once, reconcile venture arms with their parent and distinguish a stated mandate from a past deal. A current web page is not proof of remaining capital or a recent deployment. Unknown eligibility and unverified public intake are recorded openly.
Use the direct-startup family-office hub for the global capital distinction and the family-office pitch guide to prepare your introduction. Compare the broader European VC guide and the UK family-office guide without treating them as interchangeable lists.
This is general research and organizational information, not personalized financial, legal or tax advice. Confirm the current investing entity, eligibility and terms directly.